Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 27181-27190 Newer>

The Motley Fool November 9, 2007 David Lee Smith	The Mother of all Mergers, Part 2? Long in the rumor mill, a big BHP Billiton - Rio Tinto merger is finally looking like a real possibility.
The Motley Fool November 9, 2007 Sham Gad	No Pain Is More Gain Successful investors exhibit certain traits that are crucial to beating Mr. Market: sound search strategies, independent thinking, patience, and an ability to sometimes watch emotionlessly while their stock prices decline.
The Motley Fool November 9, 2007 Sham Gad	Intrinsic Value vs. Market Value Value investors are always looking for a bargain. But they should never overlook their margin of safety.
The Motley Fool November 9, 2007 Rick Aristotle Munarriz	Pies in the Sky It was a good week for pizza lovers, with Papa John's, Pizza Inn, and California Pizza Kitchen all reporting better-than-expected quarters.
The Motley Fool November 9, 2007 Ron Vlieger	ADM Plows Ahead Archer Daniels Midland turns in a good quarter, thanks to its grain and transport operations, while Wall Street ignores declines in the company's ethanol business.
The Motley Fool November 9, 2007 Alyce Lomax	Aha: Wal-Mart's Not Better Than Target Whereas many retailers had a pretty miserable October, Target showed notable strength, with same-store sales increasing by 4.1%.
The Motley Fool November 9, 2007 Seth Jayson	Another Bank Chokes on Dog Food Wachovia announces $1.1 billion in losses during October from its subprime collateralized debt obligations.
The Motley Fool November 9, 2007 Tim Beyers	Quit Calling Akamai Expensive Cash-rich Akamai has long-term growth potential and strong projected earnings, making its current valuation quite attractive. Investors, take note.
The Motley Fool November 9, 2007 Brian Lawler	GPC Regroups Pharma GPC Biotech updates investors following a surprising setback on its lead drug. Investors, take note.
The Motley Fool November 9, 2007 Brian Orelli	P&G Gives Nastech a Bloody Nose Proctor & Gamble ends its partnership with Nastech Pharmaceutical to develop a nasal spray to treat osteoporosis.
<Older 27181-27190 Newer> Return to current articles.